Dexcom Inc [NASDAQ: DXCM] surged by $0.93 during the normal trading session on Thursday and reaching a high of $130.30 during the day while it closed the day at $128.93. The company report on January 8, 2024 at 8:00 AM that Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook.
The company also announced Stelo, its new glucose sensor for people with type 2 diabetes who do not use insulin, has been submitted to the U.S. Food and Drug Administration for review and is expected to launch in the U.S. in summer 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
DexCom, Inc. (Nasdaq: DXCM), the leader in real-time continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2023 to be at least $1.030 billion, an increase of 26% over the fourth quarter of 2022. U.S. revenue is expected to be approximately $765 million, representing growth of 26% over the fourth quarter of 2022. International revenue is expected to be approximately $265 million, an increase of 27% over the fourth quarter of 2022.
Dexcom Inc stock has also gained 5.83% of its value over the past 7 days. However, DXCM stock has inclined by 63.26% in the 3 months of the year. Over the past six months meanwhile, it has lost -3.77% and gained 3.90% year-on date.
The market cap for DXCM stock reached $49.81 billion, with 386.30 million shares outstanding and 380.90 million shares in the current float. Compared to the average trading volume of 4.18M shares, DXCM reached a trading volume of 2507237 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Dexcom Inc [DXCM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DXCM shares is $142.13 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DXCM stock is a recommendation set at 1.38. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for Dexcom Inc shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on May 30, 2023.
The Average True Range (ATR) for Dexcom Inc is set at 3.58, with the Price to Sales ratio for DXCM stock in the period of the last 12 months amounting to 14.64. The Price to Book ratio for the last quarter was 21.97, with the Price to Cash per share for the same quarter was set at 8.39. Price to Free Cash Flow for DXCM in the course of the last twelve months was 99.67 with Quick ratio for the last quarter at 2.50.
DXCM stock trade performance evaluation
Dexcom Inc [DXCM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.83. With this latest performance, DXCM shares gained by 9.36% in over the last four-week period, additionally sinking by -3.77% over the last 6 months – not to mention a rise of 16.28% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DXCM stock in for the last two-week period is set at 66.57, with the RSI for the last a single of trading hit 66.93, and the three-weeks RSI is set at 65.82 for Dexcom Inc [DXCM]. The present Moving Average for the last 50 days of trading for this stock 113.49, while it was recorded at 128.05 for the last single week of trading, and 112.50 for the last 200 days.
Dexcom Inc [DXCM]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Dexcom Inc [DXCM] shares currently have an operating margin of +13.44 and a Gross Margin at +64.46. Dexcom Inc’s Net Margin is presently recorded at +11.73.
Return on Total Capital for DXCM is now 9.31, given the latest momentum, and Return on Invested Capital for the company is 8.99. Return on Equity for this stock inclined to 15.57, with Return on Assets sitting at 6.65. When it comes to the capital structure of this company, Dexcom Inc [DXCM] has a Total Debt to Total Equity ratio set at 100.62. Additionally, DXCM Total Debt to Total Capital is recorded at 50.15, with Total Debt to Total Assets ending up at 39.78. Long-Term Debt to Equity for the company is recorded at 63.42, with the Long-Term Debt to Total Capital now at 31.61.
Reflecting on the efficiency of the workforce at the company, Dexcom Inc [DXCM] managed to generate an average of $44,895 per employee. Receivables Turnover for the company is 4.60 with a Total Asset Turnover recorded at a value of 0.57.Dexcom Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.50 and a Current Ratio set at 2.80.
Earnings per share (EPS) analysis for Dexcom Inc [DXCM] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DXCM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Dexcom Inc go to 33.95%.
Dexcom Inc [DXCM]: Institutional Ownership
The top three institutional holders of DXCM stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in DXCM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in DXCM stock with ownership which is approximately 5.8325%.
